Rankings
▼
Calendar
FLGT FY 2025 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$458M
FY 2025 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$323M
+13.8% YoY
Gross Profit
$131M
40.6% margin
Operating Income
-$91M
-28.2% margin
Net Income
-$61M
-18.8% margin
EPS (Diluted)
$-1.97
Cash Flow
Operating Cash Flow
-$102M
Free Cash Flow
-$124M
Stock-Based Comp.
$40M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$107M
Stockholders' Equity
$1.1B
Cash & Equivalents
$50M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$323M
$283M
+13.8%
Gross Profit
$131M
$107M
+22.1%
Operating Income
-$91M
-$74M
-23.2%
Net Income
-$61M
-$43M
-41.7%
← Q4 2024
All Quarters
Q1 2025 →